Clinical Trial Update: Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?

View source ↗

Summary

The clinical trial NCT04319328 completed and assessed whether dosing of cefazolin, ceftazidime, and ciprofloxacin is optimal for patients undergoing hemodialysi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• CEFAZOLIN (cefazolin sodium)
• Ciprofloxacin (Ciprofloxacin hydrochloride)
• ceftazidime (ceftazidime)

Snippet

Sponsor: University of Manitoba | Conditions: Hemodialysis Complication, Infectious Disease | Status: COMPLETED